Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Weight Loss May Be a Warning Sign for Heart-Failure Patients

March 7 (Bloomberg) -- Weight loss may be harmful for heart failure patients who have implanted medical devices used to help regulate their cardiac rhythm, researchers said.

Their study of 994 patients who have devices that synchronize the heart’s contractions found those who lost even a little weight had a significantly greater risk of worsening heart failure or death. The findings, slated for presentation at the American College of Cardiology meeting this weekend in San Francisco, suggest doctors should closely monitor patients’ weight, said lead researcher Valentina Kutyifa.

The risk of worsening heart failure or death rose 4 percent with each kilogram, or 2.2 pounds, of weight lost, the study found. In patients with a condition known as left bundle branch block, weight loss doubled the danger. Heart failure typically requires high energy demand, so heavier patients may have more reserves that help them survive, Kutyifa said.

“Unplanned weight loss might be a warning sign that something bad is going on,” said Kutyifa, a research associate at the University of Rochester Medical Center in New York. “All patients who lose weight with implanted devices should have checkups and physicians should monitor them more closely,” she said in a telephone interview.

The researchers analyzed findings from the Madit-CRT trial, a study funded by Natick, Massachusetts-based Boston Scientific Corp. It is the first to show weight loss may be linked to increased health complications in patients with the devices that provide cardiac resynchronization therapy, Kutyifa said.

To contact the reporter on this story: Michelle Fay Cortez in Minneapolis at mcortez@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.